Difference between revisions of "LncRNAWiki:Mental Disorders"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Disease !width="50"|LncRNAs |- |amnestic mild cognitive impairment |''LINC01080'' |- |anorexia ...") |
|||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
+ | !width="50"|Name | ||
+ | !width="50"|Transcript ID | ||
+ | !width="50"|Alias | ||
+ | !width="50"|Description | ||
!width="50"|Disease | !width="50"|Disease | ||
− | + | ||
|- | |- | ||
− | | | + | |''BDNF-AS'' |
− | |'' | + | |[[ENST00000499008.3]] |
+ | |BDNF antisense RNA | ||
+ | |"BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049" | ||
+ | |Huntington's disease, psychiatric disease, schizophrenia, obesity | ||
+ | |- | ||
+ | |''DISC2'' | ||
+ | |[[NONHSAT010191]] | ||
+ | |"DISC1-AS1, DISC1OS, NCRNA00015" | ||
+ | |disrupted in schizophrenia 2 (non-protein coding) | ||
+ | |affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia | ||
+ | |- | ||
+ | |''HAR1A'' | ||
+ | |[[lnc-BIRC7-2:1]] | ||
+ | |"HAR1F, ENSG00000238820" | ||
+ | |highly accelerated region 1A | ||
+ | |Alzheimer's disease,Huntington's disease, schizophrenia | ||
+ | |- | ||
+ | |''HAR1B'' | ||
+ | |[[ENST00000447910.2]] | ||
+ | |"HAR1R, ENSG00000231133" | ||
+ | |highly accelerated region 1B | ||
+ | |Huntington's disease, schizophrenia | ||
+ | |- | ||
+ | |''MEG3'' | ||
+ | |[[NONHSAT039745]] | ||
+ | |"Gtl2, ENSG00000214548" | ||
+ | |maternally expressed 3 (non-protein coding) | ||
+ | |bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes | ||
+ | |- | ||
+ | |''TUG1'' | ||
+ | |[[NONHSAT084827]] | ||
+ | |ENSG00000253352 | ||
+ | |taurine up-regulated gene 1 | ||
+ | |B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer | ||
+ | |- | ||
+ | |''DAOA-AS1'' | ||
+ | |[[DAOA-AS1]] | ||
+ | |G30 | ||
+ | |DAOA antisense RNA 1 | ||
+ | |bipolar illness,schizophrenia | ||
+ | |- | ||
+ | |''FOXG1-AS1'' | ||
+ | |[[FOXG1-AS1]] | ||
+ | |FOXG1-AS | ||
+ | |FOXG1 antisense RNA 1 (head to head) | ||
+ | |autism spectrum disorders | ||
+ | |- | ||
+ | |''HTT-AS'' | ||
+ | |[[HTT-AS]] | ||
+ | |HTTAS | ||
+ | |HTT antisense RNA (head to head) | ||
+ | |Huntington's disease | ||
|- | |- | ||
− | |||
|''LINC00235'' | |''LINC00235'' | ||
+ | |[[LINC00235]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 235 | ||
+ | |_ | ||
|- | |- | ||
+ | |''LINC00942'' | ||
+ | |[[LINC00942]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 942 | ||
|autism spectrum disorder | |autism spectrum disorder | ||
− | |||
|- | |- | ||
− | + | |''LINC01080'' | |
− | |'' | + | |[[LINC01080]] |
+ | |TCONSN/A00021856 | ||
+ | |long intergenic non-protein coding RNA 1080 | ||
+ | |Alzheimer's disease ;amnestic mild cognitive impairment | ||
|- | |- | ||
− | + | |''NOP14-AS1'' | |
− | | | + | |[[NOP14-AS1]] |
+ | |RES4-24 | ||
+ | |NOP14 antisense RNA 1 | ||
+ | |Huntington disease | ||
|- | |- | ||
− | |||
|''TSIX'' | |''TSIX'' | ||
− | | | + | |[[TSIX]] |
+ | |"NCRNA00013, XIST-AS1, LINC00013" | ||
+ | |"TSIX transcript, XIST antisense RNA" | ||
+ | |_ | ||
+ | |- |
Latest revision as of 04:18, 30 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
BDNF-AS | ENST00000499008.3 | BDNF antisense RNA | "BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049" | Huntington's disease, psychiatric disease, schizophrenia, obesity |
DISC2 | NONHSAT010191 | "DISC1-AS1, DISC1OS, NCRNA00015" | disrupted in schizophrenia 2 (non-protein coding) | affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia |
HAR1A | lnc-BIRC7-2:1 | "HAR1F, ENSG00000238820" | highly accelerated region 1A | Alzheimer's disease,Huntington's disease, schizophrenia |
HAR1B | ENST00000447910.2 | "HAR1R, ENSG00000231133" | highly accelerated region 1B | Huntington's disease, schizophrenia |
MEG3 | NONHSAT039745 | "Gtl2, ENSG00000214548" | maternally expressed 3 (non-protein coding) | bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes |
TUG1 | NONHSAT084827 | ENSG00000253352 | taurine up-regulated gene 1 | B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer |
DAOA-AS1 | DAOA-AS1 | G30 | DAOA antisense RNA 1 | bipolar illness,schizophrenia |
FOXG1-AS1 | FOXG1-AS1 | FOXG1-AS | FOXG1 antisense RNA 1 (head to head) | autism spectrum disorders |
HTT-AS | HTT-AS | HTTAS | HTT antisense RNA (head to head) | Huntington's disease |
LINC00235 | LINC00235 | N/A | long intergenic non-protein coding RNA 235 | _ |
LINC00942 | LINC00942 | N/A | long intergenic non-protein coding RNA 942 | autism spectrum disorder |
LINC01080 | LINC01080 | TCONSN/A00021856 | long intergenic non-protein coding RNA 1080 | Alzheimer's disease ;amnestic mild cognitive impairment |
NOP14-AS1 | NOP14-AS1 | RES4-24 | NOP14 antisense RNA 1 | Huntington disease |
TSIX | TSIX | "NCRNA00013, XIST-AS1, LINC00013" | "TSIX transcript, XIST antisense RNA" | _ |